Instant and accurate evaluation of drug resistance in tumors before and during chemotherapy is important for patients with advanced colon cancer and is beneficial for prolonging their progression-free survival time. Here, the possible biomarkers that reflect the drug resistance of colon cancer were investigated using proton magnetic resonance spectroscopy (1H-MRS) in vivo. SW480[5-fluorouracil(5-FU)-responsive] and SW480/5-FU (5-FU-resistant) xenograft models were generated and subjected to in vivo 1H-MRS examinations when the maximum tumor diameter reached 1–1.5 cm. The areas under the peaks for metabolites, including choline (Cho), lactate (Lac), glutamine/glutamate (Glx), and myo-inositol (Ins)/creatine (Cr) in the tumors, were analyzed between two groups. The resistance-related protein expression, cell morphology, necrosis, apoptosis, and cell survival of these tumor specimens were assessed. The content for tCho, Lac, Glx, and Ins/Cr in the tumors of the SW480 group was significantly lower than that of the SW480/5-FU group (P < 0.05). While there was no significant difference in the degree of necrosis and apoptosis rate of tumor cells between the two groups (P > 0.05), the tumor cells of the SW480/5-FU showed a higher cell density and larger nuclei. The expression levels of resistance-related proteins (P-gp, MPR1, PKC) in the SW480 group were lower than those in the SW480/5-FU group (P < 0.01). The survival rate of 5-FU-resistant colon cancer cells was significantly higher than that of 5-FU-responsive ones at 5-FU concentrations greater than 2.5 μg/mL (P < 0.05). These results suggest that alterations in tCho, Lac, Glx1, Glx2, and Ins/Cr detected by 1H-MRS may be used for monitoring tumor resistance to 5-FU in vivo.

Brain tumors are a primary factor causing cancer-related deaths globally, and their classification remains a significant research challenge due to the variability in tumor intensity, size, and shape, as well as the similar appearances of different tumor types. Accurate differentiation is further complicated by these factors, making diagnosis difficult even with advanced imaging techniques such as magnetic resonance imaging (MRI). Recent techniques in artificial intelligence (AI), in particular deep learning (DL), have improved the speed and accuracy of medical image analysis, but they still face challenges like overfitting and the need for large annotated datasets. This study addresses these challenges by presenting two approaches for brain tumor classification using MRI images. The first approach involves fine-tuning transfer learning cutting-edge models, including SEResNet, ConvNeXtBase, and ResNet101V2, with global average pooling 2D and dropout layers to minimize overfitting and reduce the need for extensive preprocessing. The second approach leverages the Vision Transformer (ViT), optimized with the AdamW optimizer and extensive data augmentation. Experiments on the BT-Large-4C dataset demonstrate that SEResNet achieves the highest accuracy of 97.96%, surpassing ViT’s 95.4%. These results suggest that fine-tuning and transfer learning models are more effective at addressing the challenges of overfitting and dataset limitations, ultimately outperforming the Vision Transformer and existing state-of-the-art techniques in brain tumor classification.

The human brain has been described as a complex system. Its study by means of neurophysiological signals has revealed the presence of linear and nonlinear interactions. In this context, entropy metrics have been used to uncover brain behavior in the presence and absence of neurological disturbances. Entropy mapping is of great interest for the study of progressive neurodegenerative diseases such as Alzheimer’s disease. The aim of this study was to characterize the dynamics of brain oscillations in such disease by means of entropy and amplitude of low frequency oscillations from Bold signals of the default network and the executive control network in Alzheimer’s patients and healthy individuals, using a database extracted from the Open Access Imaging Studies series. The results revealed higher discriminative power of entropy by permutations compared to low-frequency fluctuation amplitude and fractional amplitude of low-frequency fluctuations. Increased entropy by permutations was obtained in regions of the default network and the executive control network in patients. The posterior cingulate cortex and the precuneus showed differential characteristics when assessing entropy by permutations in both groups. There were no findings when correlating metrics with clinical scales. The results demonstrated that entropy by permutations allows characterizing brain function in Alzheimer’s patients, and also reveals information about nonlinear interactions complementary to the characteristics obtained by calculating the amplitude of low frequency oscillations.

The changes the magnetic flux generated (electric, magnetic and electromagnetic waves) on the surface of earth due to sudden changes is a matter of discussion. These emissions occur along the fault line generated due to geological and tectonic processes. When sudden changes occur in the environment due to seismic and atmospheric variations, these sensing was observed by creatures and human bodies because the animals and trees adopt the abnormal signals and change the behavior. We have analyzed the changing behavior of recorded signal by live sensors (i.e., banyan tree). So we use the deep-rooted and long-aged banyan tree. The root of banyan tree (long-aged) has been working as a live sensor to record the geological and environmental changes. We record the low frequency signals propagated through solar-terrestrial environment which directly affect the root system of the banyan tree and changes that have been observed by live sensors. Then, very low frequency (VLF) signal may propagate to the earth-ionosphere waveguide. We have also analyzed the different parameters of live cells which is inbuilt in latex of the tree, so we record the dielectric parameters of green stem latex and found some parameters i.e., dielectric constant (ε) and dielectric loss (ε’) of various trees to verify these natural hazards and found good correlation. Therefore, we can say by regularly monitoring the bio-potential signal and dielectric properties of banyan tree and we are able to find the precursory signature of seismic hazards and environmental changes.

Multiple myeloma (MM) is a hematologic cancer characterized by clonal proliferation of plasma cells within the bone marrow. It is the most serious form of plasma cell dyscrasias, whose complications—hypercalcemia, renal failure, anemia, and lytic bone lesions—are severe and justify the therapeutic management. Imaging of bone lesions is a cardinal element in the diagnosis, staging, study of response to therapy, and prognostic evaluation of patients with MM. Historically, the skeletal radiographic workup (SRW), covering the entire axial skeleton, has been used to detect bone lesions. Over time, new imaging techniques that are more powerful than SRW have been evaluated. Low-dose and whole-body computed tomography (CT) supplants SRW for the detection of bone involvement, but is of limited value in assessing therapeutic response. Bone marrow MRI, initially studying the axial pelvic-spinal skeleton and more recently the whole body, is an attractive alternative. Beyond its non-irradiating character, its sensitivity for the detection of marrow damage, its capacity to evaluate the therapeutic response and its prognostic value has been demonstrated. This well-established technique has been incorporated into disease staging systems by many health systems and scientific authorities. Along with positron emission tomography (PET)-18 fluorodeoxyglucose CT, it constitutes the current imaging of choice for MM. This article illustrates the progress of the MRI technique over the past three decades and situates its role in the management of patients with MM.

Background: Multiple sclerosis is often a longitudinal disease continuum with an initial relapsing-remitting phase (RRMS) and later secondary progression (SPMS). Most currently approved therapies are not sufficiently effective in SPMS. Early detection of SPMS conversion is therefore critical for therapy selection. Important decision-making tools may include testing of partial cognitive performance and magnetic resonance imaging (MRI). Aim of the work: To demonstrate the importance of cognitive testing and MRI for the prediction and detection of SPMS conversion. Elaboration of strategies for follow-up and therapy management in practice, especially in outpatient care. Material and methods: Review based on an unsystematic literature search. Results: Standardized cognitive testing can be helpful for early SPMS diagnosis and facilitate progression assessment. Annual use of sensitive screening tests such as Symbol Digit Modalities Test (SDMT) and Brief Visual Memory Test-Revised (BVMT-R) or the Brief International Cognitive Assessment for MS (BICAMS) test battery is recommended. Persistent inflammatory activity on MRI in the first three years of disease and the presence of cortical lesions are predictive of SPMS conversion. Standardized MRI monitoring for features of progressive MS can support clinically and neurocognitively based suspicion of SPMS. Discussion: Interdisciplinary care of MS patients by clinically skilled neurologists, supported by neuropsychological testing and MRI, has a high value for SPMS prediction and diagnosis. The latter allows early conversion to appropriate therapies, as SPMS requires different interventions than RRMS. After drug switching, clinical, neuropsychological, and imaging vigilance allows stringent monitoring for neuroinflammatory and degenerative activity as well as treatment complications.